Latest News about JNJ
Recent news which mentions JNJ
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal
January 13, 2025
From Benzinga
2 Beaten-Down Dividend Stocks to Buy in 2025
January 13, 2025
From Motley Fool
4 Top Dividend Growth Stocks to Build Your Portfolio Around in 2025
January 10, 2025
From Motley Fool
2 Dow Stocks to Buy Hand Over Fist in 2025 and 1 to Avoid
January 10, 2025
From Motley Fool
Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events
January 09, 2025
From Benzinga
8 Health Care Stocks Whale Activity In Today's Session
January 08, 2025
From Benzinga
Where to Invest $100,000 in 2025
January 08, 2025
From Motley Fool
Stock Of The Day: Will Johnson & Johnson Take The Market Lower?
January 06, 2025
Tickers
JNJ
From Benzinga
10 Stock Market Predictions for 2025
January 01, 2025
From Motley Fool
Marjorie Taylor Greene Went Christmas Shopping For Stocks, Here's What She Bought Before Holiday
December 31, 2024
From Benzinga
From Benzinga
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
December 31, 2024
From Benzinga
5 Unbeatable Stocks I'm Eager to Buy in 2025
December 30, 2024
From Motley Fool
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
December 27, 2024
Tickers
JNJ
From Benzinga
The Smartest Dividend Stocks to Buy With $1,000 Right Now
December 26, 2024
From Motley Fool
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
December 25, 2024
From Benzinga
Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks
December 24, 2024
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
The Smartest Dividend Stocks to Buy With $500 Right Now
December 18, 2024
From Motley Fool
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
December 17, 2024
From Benzinga
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
December 13, 2024
Tickers
JNJ
From Benzinga
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
December 12, 2024
From Motley Fool
From Benzinga
Jim Cramer Bullish On Netflix Nearing $1,000 And AMD's 'Cheap' Valuation Despite Nvidia Dominance
December 11, 2024
From Benzinga
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
December 10, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
